Oakland, N.J., Groningen, The Netherlands, October 5, 2022 – Collagen Matrix, Inc. (“Collagen Matrix”), a global leader in regenerative medicine and a Linden Capital Partners (“Linden”) portfolio company, today announced the acquisition of Polyganics, B.V (“Polyganics”). Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix’s portfolio […]
Polyganics is op zoek naar een ervaren en gedreven Operationeel Inkoper. Breng jij ons naar de volgende stap in het optimaliseren van onze inkoopprocessen? Polyganics Polyganics is een medische technologie onderneming, in 1999 opgericht als een spin-off van de Rijksuniversiteit Groningen. Polyganics doet al meer dan 20 jaar onderzoek naar biologisch afbreekbare medische implantaten. Polyganics […]
R&D Technicus Ons bedrijf Polyganics ontwikkelt, produceert en verkoopt wereldwijd biologisch afbreekbare medische producten. Onze producten worden gemaakt van bio-afbreekbare synthetische polymeren. Ze worden door het lichaam afgebroken, waardoor er na een operatie in een later stadium geen chirurgische ingreep meer nodig is om ze te verwijderen. Dat maakt onze producten zeer patiëntvriendelijk, veilig en […]
Our company Polyganics develops and manufactures innovative, bioresorbable, biocompatible, synthetic polymer-based medical devices, that facilitate natural tissue repair and regeneration. The job As an Operator/ Polymer technician, you are responsible for polymer production, performing of tests and characterizations. In addition, you provide assistance with the development, production and packaging of medical devices Your tasks – […]
Ons bedrijf Polyganics ontwikkelt, produceert en verkoopt wereldwijd biologisch afbreekbare medische producten. Onze producten worden gemaakt van bio-afbreekbare synthetische polymeren. Ze worden door het lichaam afgebroken, waardoor er na een operatie in een later stadium geen chirurgische ingreep meer nodig is om ze te verwijderen. Dat maakt onze producten zeer patiëntvriendelijk, veilig en kostenbesparend. Wat […]
Our company Polyganics is an innovative, privately held medical technology company bringing to market unique bioresorbable devices to facilitate tissue repair and regeneration after surgery. From its ISO 13485-certified manufacturing facility, products are distributed to customers worldwide. Polyganics has recently moved to a new facility at the Zernike Campus, Groningen, which houses its headquarters, state-of-the-art […]
Our company Polyganics is an innovative medical technology company. We develop, manufacture and commercialize worldwide, innovative bioresorbable devices to facilitate tissue repair and regeneration after surgery. We adapt our versatile polymers for different clinical applications, improving surgical outcome and patient recovery. The job As one of our Manufacturing engineers you will be improving our processes […]
Randomized controlled trial in the US and Europe will enable LIQOSEAL to be submitted for FDA approval Groningen, The Netherlands, May 21 2021 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patient in its ENCASE II clinical trial for LIQOSEAL. LIQOSEAL is an easy-to-use, […]
Groningen, The Netherlands, 20 April 2021 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announces its move to a state-of-the art, purpose-built facility on the Zernike Campus, Groningen. The new building will house Polyganics’ research laboratories, manufacturing and packaging facilities, and its offices. The expansion is essential to accommodate […]
Groningen, The Netherlands, 15 September 2020 – Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patients in its first-in-human study for ACTISEAL®, its Liver and Pancreas Sealant Patch. The ‘SHIELDS’ trial is a prospective, multicenter study, evaluating the safety and performance of ACTISEAL® in reducing […]
